vimarsana.com

Page 359 - வாஷிங்டன் பல்கலைக்கழகம் இல் ஸ்டம்ப் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Fluvoxamine: Finding a possible early treatment for COVID-19 in a 40-year-old antidepressant - 60 Minutes

The race to find vaccines for COVID-19 has dominated the headlines, but there s been less news about how to keep people with COVID out of the hospital. Tonight, we re going to tell you a story about one possible treatment. It s called fluvoxamine. The generic drug was developed 40 years ago as an antidepressant and has been primarily used to treat obsessive-compulsive disorder. Now, a small but ingenious clinical trial and a series of coincidences have led scientists to look closely at fluvoxamine as a possible tool to keep newly diagnosed COVID-19 patients from becoming severely ill. So how did a pill that costs 60 cents become a dark horse to treat COVID? We went to a place that knows all about long shots to find out.

Zetchers provide major commitment for scholarships, paving the way for need-blind admissions | The Source

South 40 House to be renamed in recognition of their support March 8, 2021 SHARE Washington University in St. Louis alumnus and emeritus trustee Arnold B. Zetcher and his wife, Ellen, have made a significant commitment to establish an endowed scholarship for undergraduate students, announced Chancellor Andrew D. Martin. Arnold and Ellen Zetcher (Photo: Jason Elias) The Arnold and Ellen Zetcher Scholarship will be open to students with financial need entering any of the university’s four undergraduate schools. The Zetchers’ commitment of at least $8 million in outright and estate gifts will advance the university’s effort to adopt a need-blind admissions policy, a goal that Martin announced during his October 2019 inaugural address. 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.